The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Immunochemistry Diagnostic Devices And Equipment Market During 2026–2030?
The size of the immunochemistry diagnostic devices and equipment market has experienced rapid growth in recent years. It is anticipated to expand from $3.67 billion in 2025 to $4.11 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.9%. Historically, this growth can be attributed to the increase in clinical diagnostic testing volumes, the rising occurrence of chronic and infectious diseases, the expansion of centralized diagnostic laboratories, a greater application of immunoassays in oncology and endocrinology, and advancements in laboratory infrastructure.
The immunochemistry diagnostic devices and equipment market is projected to experience swift expansion over the coming years. Its valuation is anticipated to reach $6.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This growth during the forecast period is attributable to several factors, including the escalating demand for accurate diagnostics, increased uptake of automated laboratory systems, the broadening scope of personalized medicine, greater investment in cutting-edge diagnostic technologies, and a heightened emphasis on detecting diseases early. Key developments expected over the forecast period encompass a surge in the adoption of automated immunoassay analyzers, a heightened need for highly sensitive diagnostic reagents, increased utilization of multiplex testing platforms, an expansion of solutions for laboratory automation, and a stronger emphasis on optimizing workflow efficiency and precision.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2547&type=smp
What Core Drivers Are Transforming The Immunochemistry Diagnostic Devices And Equipment Market?
The escalating demand for personalized medicine is projected to stimulate the expansion of the immunochemistry diagnostic devices and equipment market. Personalized medicine represents a medical methodology that customizes healthcare choices and treatment plans based on an individual’s distinct genetic, genomic, and clinical attributes, with the goal of optimizing patient outcomes and minimizing adverse effects. The increasing call for personalized medicine arises from heightened awareness and acceptance of customized treatments that take into account individual genetic, lifestyle, and environmental elements to enhance patient results. Personalized medicine mandates the advancement and application of sophisticated immunochemistry assays to pinpoint specific biomarkers and guide individualized treatment approaches for patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization advocating for individualized treatment methods, reported that 20 of the 53 new therapeutic molecular entities approved by the Food and Drug Administration in 2023, along with six new gene and cell-based therapies, were categorized as personalized medicines, making up approximately 38 percent of all new molecular entities approved in the country. Consequently, the growing demand for personalized medicine is fueling the growth of the immunochemistry diagnostic devices and equipment market moving forward.
Which Segment-Based Categories Are Covered In The Immunochemistry Diagnostic Devices And Equipment Market?
The immunochemistry diagnostic devices and equipment market covered in this report is segmented –
1) By Product Type: Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables
2) By Consumables: Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, Other Consumables
3) By Application: Endocrinology, Oncology, Cardiology, Therapeutic Drug Development And Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing, Other Applications
4) By End Users: Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Immunochemistry Analyzers: Chemiluminescence Immunoassay (CLIA) Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Radioimmunoassay (RIA) Analyzers, Fluorescence Immunoassay (FIA) Analyzers
2) By Immunochemistry Stainers: Automated Stainers, Manual Stainers
3) By Incubators: CO2 Incubators, Shaking Incubators, Heated Incubators
4) By Microscopes: Light Microscopes, Fluorescence Microscopes, Electron Microscopes
5) By Centrifuges: Microcentrifuges, Refrigerated Centrifuges, Ultracentrifuges
6) By Autoclaves: Tabletop Autoclaves, Vertical Autoclaves, Horizontal Autoclaves
7) By Consumables: Reagents and Kits, Test Plates, Filters and Membranes, Microplates and Accessories
Which Trends Are Shaping The Immunochemistry Diagnostic Devices And Equipment Market Landscape?
Leading companies operating within the immunochemistry market are developing new offerings, such as multiplex assays, to secure a competitive advantage. Multiplex assays are laboratory techniques that facilitate the simultaneous measurement and analysis of multiple analytes within a single biological sample, providing a comprehensive and efficient method for studying numerous factors or biomarkers in a single experiment. For example, in June 2023, Navigate BioPharma Services, Inc., a US-based biotechnology company, unveiled new multiplex digital PCR assays tailored for the precise quantification of chimeric antigen receptor (CAR) T cells, a significant breakthrough in cancer immunotherapy. These assays, built upon the Qiagen QIAcuity digital PCR System, enable concurrent measurement of CAR-T cell number, function, and persistence in clinical blood and bone marrow samples without requiring standard curves, capable of detecting CAR-T cells at levels as low as 0.01%. This innovative assay supports clinicians in monitoring responses and safety during clinical trials, thereby promoting the advancement of CAR-T therapies due to its sensitivity, specificity, and efficiency.
Which Organizations Are Operating Within The Immunochemistry Diagnostic Devices And Equipment Market?
Major companies operating in the immunochemistry diagnostic devices and equipment market are Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, Diamond Diagnostics Inc., Dynex Technologies Inc., Grifols S.A., Hycor Biomedical LLC, Immunodiagnostic Systems, Inova Diagnostics, LabCorp, Mindray Medical International Limited, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories, Sysmex Corporation, ThermoFisher Scientific Inc., Tosoh Bioscience, Danaher Corporation, Johnson & Johnson, Boditech Med Inc., Beckman Coulter Inc., Bio-Rad Laboratories, bioMérieux Clinical Diagnostics, Carolina Liquid Chemistries Corporate, DiaSorin Inc., Agilent Technologies Inc., Merck KGAA, Eagle Biosciences Inc., Biocare Medical LLC, Elabscience Biotechnology Inc., Bio-Genex Laboratories Inc., Diagnostic Biosystem, Histo-Line Laboratories, Rockland Immunochemicals Inc., Abcam plc, Becton Dickinson & Company, Cell Signaling Technology Inc., ImmunoChemistry Technologies LLC, Genemed Biotechnologies Inc., Miltenyi Biotec GmbH, PerkinElmer Inc., Takara Bio. Inc, Immucor Inc., Quidel Corporation
Access The Complete Immunochemistry Diagnostic Devices And Equipment Market Report:
Which Region Is The Dominant Market In The Immunochemistry Diagnostic Devices And Equipment Market?
North America was the largest region in the global immunochemistry diagnostic devices and equipment market in 2025. Asia-Pacific was the second-largest region in the immunochemistry diagnostic devices and equipment market. The regions covered in the immunochemistry diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Immunochemistry Diagnostic Devices And Equipment Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Immunochemistry Diagnostic Devices And Equipment Market 2026, By The Business Research Company
Hematology Diagnostic Devices And Equipment Market Report 2026
Automated Immunoassay Analyzers Market Report 2026
Molecular Diagnostics Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model